During the past decade, Israel Hartman MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Israel Hartman MD" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Israel Hartman MD" are "Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Non-Insulin-Dependent" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetes Type 2" (1 trials) and "Diabetes, Type I" (1 trials). Many other conditions were trialed in "Israel Hartman MD" in a lesser frequency.

Most popular intervention types in "Israel Hartman MD" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "AC2993" (2 trials), "Technosphere Insulin Inhalation Powder" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Active comparator" (1 trials) and "Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Israel Hartman MD" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Israel Hartman MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Israel Hartman MD, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Israel Hartman MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".